谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-Term Efficacy and Safety Results from the Phase 1/2 MonumenTAL-1 Study of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Leo Rasche,Carolina Schinke,Cyrille Touzeau,Monique C. Minnema,Niels W. C. J. van de Donk,Paula Rodriguez-Otero,Maria-Victoria Mateos,Jing Christine Ye,Deeksha Vishwamitra, Indrajeet Singh,Xiang Qin,Michela Campagna, Tara Masterson,Brandi W. Hilder,Jaszianne Tolbert,Thomas Renaud,Christoph Heuck,Colleen Kane,Ajai Chari

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要